Sugammadex versus neostigmine for antagonism of rocuronium-induced neuromuscular blockade in infants with biliary atresia undergoing kasai operation . A randomized control trial
Phase 2
Not yet recruiting
- Conditions
- Anaesthesia
- Registration Number
- PACTR201907522427588
- Lead Sponsor
- ational liver institute
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
infants aged below 3 months undergoing kasai operation.
-American Society of Anesthesiologists physical status class I-II
Exclusion Criteria
-Co-existing known or suspected neuromuscular disease, renal impairment, medications known to affect neuromuscular transmission e.g. aminoglycoside antibiotics or magnesium sulphate, bleeding tendency, and intraoperative events e.g. (massive bleeding and hypothermia).
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The time from the start of sugammadex or neostigmine administration to recovery of the train of four (TOF ratio to 0.9.)
- Secondary Outcome Measures
Name Time Method -Duration of anaesthesia and surgery